Filing Flows › Comparisons › RMD vs WST
ResMed vs West Pharmaceutical Services: RMD and WST compared
ResMed is the larger company: $1.4B of revenue in its latest quarter (Q1 FY27) against $874M for West Pharmaceutical Services (Q3 2026). West Pharmaceutical Services is growing faster (+9% against +6% a year earlier). ResMed is more profitable, with an operating margin of 32.0% against 30.6%.
Where the money goes: RMD and WST
ResMed (RMD) · Q1 FY27
ResMed, Q1 FY27: revenue $1.4B (+6% year over year), operating margin 32.0%, net earnings $418M, operating cash flow $422M. The chart follows the revenue to costs, profit and cash.
West Pharmaceutical Services (WST) · Q3 2026
West Pharmaceutical Services, Q3 2026: revenue $874M (+9% year over year), operating margin 30.6%, net earnings $214M, operating cash flow $190M. The chart follows the revenue to costs, profit and cash.
| ResMed (RMD) | West Pharmaceutical Services (WST) | |
|---|---|---|
| Latest quarter | Q1 FY27 | Q3 2026 |
| Revenue | $1.4B | $874M |
| Revenue growth, Y/Y | +6% | +9% |
| Gross margin | 61.5% | 39.7% |
| Operating margin | 32.0% | 30.6% |
| Net earnings | $418M | $214M |
| Net margin | 29.6% | 24.5% |
| Operating cash flow | $422M | $190M |
| Free cash flow | $374M | $150M |
| Market value | $33.5B | $28.3B |
| P/E | 21.3× | 44.9× |
| Analysts’ mean target | $264.33 | $471.00 |
Where the revenue comes from
ResMed
- Total Sleep and Breathing Health: $1.3B (89%)
- Residential Care Software: $155M (11%)
West Pharmaceutical Services
- Proprietary Products: $729M (83%)
- West Vantage: $146M (17%)
Questions
Which is bigger, ResMed or West Pharmaceutical Services?
ResMed is the larger company: $1.4B of revenue in its latest quarter (Q1 FY27) against $874M for West Pharmaceutical Services (Q3 2026).
Is ResMed or West Pharmaceutical Services growing faster?
West Pharmaceutical Services is growing faster (+9% against +6% a year earlier).
Which is more profitable, ResMed or West Pharmaceutical Services?
ResMed is more profitable, with an operating margin of 32.0% against 30.6%.
More: ResMed earnings · how ResMed makes money · West Pharmaceutical Services earnings · how West Pharmaceutical Services makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Oct 30, 2026; 10-Q filed Oct 29, 2026). Fiscal quarters can end on different dates. Not investment advice.